Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth: Commentary

Obstetrics and Gynecology

Volumn 109, Issue 1, 2007, Pages 189-190

  Neilson, James P ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE;

ASSISTED VENTILATION; BRAIN HEMORRHAGE; CHORIOAMNIONITIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS LUNG MATURATION; FETUS MORTALITY; HUMAN; HYPERTENSION; INFANT; INFECTION; MATERNAL MORTALITY; MEMBRANE RUPTURE; MORBIDITY; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NOTE; PREGNANCY RATE; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL DISORDER; RESPIRATORY DISTRESS SYNDROME; RISK; RISK FACTOR;

EID: 33845961439     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000251610.51286.b1     Document Type: Note

References (3)

1. Wellcome Trust Centre. Prenatal corticosteroids for reducing morbidity and mortality after preterm birth. Witness Seminar, Wellcome Trust Centre for the History of Medicine, June 2004. Available at: http://library.wellcome.ac.uk/ witnessseminars/wit25.pdf. Retrieved October 31, 2006.
2. Crowther CA, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
3. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS; for ACTORDS Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006;367:1913-9.